Morgan Stanley’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.6M | Buy |
1,226,339
+12,670
| +1% | +$533K | ﹤0.01% | 1904 |
|
|
2025
Q1 | $46M | Buy |
1,213,669
+50,143
| +4% | +$1.9M | ﹤0.01% | 1884 |
|
|
2024
Q4 | $89.5M | Buy |
1,163,526
+1,083,026
| +1,345% | +$83.3M | 0.01% | 1340 |
|
|
2024
Q3 | $4.63M | Sell |
80,500
-103,819
| -56% | -$5.97M | ﹤0.01% | 4018 |
|
|
2024
Q2 | $7.62M | Buy |
184,319
+84,183
| +84% | +$3.48M | ﹤0.01% | 3539 |
|
|
2024
Q1 | $6.11M | Buy |
100,136
+66,270
| +196% | +$4.04M | ﹤0.01% | 3760 |
|
|
2023
Q4 | $755K | Buy |
33,866
+14,518
| +75% | +$323K | ﹤0.01% | 5436 |
|
|
2023
Q3 | $496K | Buy |
19,348
+3,148
| +19% | +$80.7K | ﹤0.01% | 5177 |
|
|
2023
Q2 | $279K | Sell |
16,200
-39,036
| -71% | -$673K | ﹤0.01% | 5494 |
|
|
2023
Q1 | $670K | Buy |
55,236
+43,099
| +355% | +$523K | ﹤0.01% | 5086 |
|
|
2022
Q4 | $433K | Sell |
12,137
-6,188
| -34% | -$221K | ﹤0.01% | 5314 |
|
|
2022
Q3 | $624K | Sell |
18,325
-16,823
| -48% | -$573K | ﹤0.01% | 5152 |
|
|
2022
Q2 | $1.29M | Buy |
35,148
+30,341
| +631% | +$1.11M | ﹤0.01% | 4852 |
|
|
2022
Q1 | $737K | Buy |
4,807
+3,454
| +255% | +$530K | ﹤0.01% | 5172 |
|
|
2021
Q4 | $400K | Buy |
1,353
+387
| +40% | +$114K | ﹤0.01% | 5681 |
|
|
2021
Q3 | $267K | Sell |
966
-5,702
| -86% | -$1.58M | ﹤0.01% | 5849 |
|
|
2021
Q2 | $1.83M | Buy |
6,668
+6,374
| +2,168% | +$1.75M | ﹤0.01% | 4698 |
|
|
2021
Q1 | $144K | Sell |
294
-661
| -69% | -$324K | ﹤0.01% | 5832 |
|
|
2020
Q4 | $788K | Buy |
+955
| New | +$788K | ﹤0.01% | 4794 |
|